Evidence map›Paper›PMID 27048419›Full record

ArticleJournal of the American Society for Mass Spectrometry2016

Structural Characterization of Missense Mutations Using High Resolution Mass Spectrometry: A Case Study of the Parkinson's-Related Protein, DJ-1.

Gili Ben-Nissan, Almog Chotiner, Mark Tarnavsky, Michal Sharon

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Mass Spectrometry: A Technique of Many Faces.Quarterly reviews of biophysics · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gili Ben-NissanDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Almog ChotinerDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Mark TarnavskyDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Michal SharonDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel. michal.sharon@weizmann.ac.il.
Weizmann Institute of Science · IL

Funding

European Research Council 636752
6 · The paper itself

Abstract

Missense mutations that lead to the expression of mutant proteins carrying single amino acid substitutions are the cause of numerous diseases. Unlike gene lesions, insertions, deletions, nonsense mutations, or modified RNA splicing, which affect the length of a polypeptide, or determine whether a polypeptide is translated at all, missense mutations exert more subtle effects on protein structure, which are often difficult to evaluate. Here, we took advantage of the spectral resolution afforded by the EMR Orbitrap platform, to generate a mass spectrometry-based approach relying on simultaneous measurements of the wild-type protein and the missense variants. This approach not only considerably shortens the analysis time due to the concurrent acquisition but, more importantly, enables direct comparisons between the wild-type protein and the variants, allowing identification of even subtle structural changes. We demonstrate our approach using the Parkinson's-associated protein, DJ-1. Together with the wild-type protein, we examined two missense mutants, DJ-1A104T and DJ-1D149A, which lead to early-onset familial Parkinson's disease. Gas-phase, thermal, and chemical stability assays indicate clear alterations in the conformational stability of the two mutants: the structural stability of DJ-1D149A is reduced, whereas that of DJ-1A104T is enhanced. Overall, we anticipate that the methodology presented here will be applicable to numerous other missense mutants, promoting the structural investigations of multiple variants of the same protein. Graphical Abstract ᅟ.

Indexed as

Mass SpectrometryMutation, MissenseHumansIntracellular Signaling Peptides and ProteinsOncogene ProteinsParkinson DiseaseProtein Deglycase DJ-1Intracellular Signaling Peptides and ProteinsOncogene ProteinsPARK7 protein, humanProtein Deglycase DJ-1DJ-1Missense mutationsNative mass spectrometryOrbitrap EMR mass spectrometerParkinson’s disease

Identifiers

PMID27048419
PMCPMC5152731
OpenAlexW2332540610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.